Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
europe blog main
europe top stories
fda
life sciences
national
2
×
national blog main
san francisco blog main
san francisco top stories
abaloparatide
amgen
arena pharmaceuticals
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
cardiovascular disease
colorectal cancer
detroit blog main
detroit top stories
eisai
european commission
indiana blog main
indiana top stories
lorcaserin
lung cancer
national top stories
new york blog main
new york top stories
obsesity
orexigen therapeutics
osteoporosis
pancreatic cancer
product recalls
radius health
raleigh-durham blog main
raleigh-durham top stories
romosozumab
What
drug
marketing
2
×
medicine
amgen
amgen’s
approval
cancer
carries
developed
eisai
europe
european
fda
flags
heart
higher
incidence
lorcaserin
loss
market
nod
osteoporosis
patients
post
pulls
raise
risk
risks
study
took
warning
weight
wins
withdrawing
Language
unset
Current search:
marketing
×
national
×
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning
